Graphite Bio Inc. (GRPH) NASDAQ
$2.19 0.03 (1.39%)
Market Cap: $125.22M
As of 05/25/22 04:00 PM EDT. Market closed.
Graphite Bio Inc. (GRPH) NASDAQ
$2.19 0.03 (1.39%)
Market Cap: $125.22M
As of 05/25/22 04:00 PM EDT. Market closed.
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
27
URL
Address
.
PRICE CHART
From:
To:
KEY STATS
Open
$2.13
Previous Close
$2.16
Days Range
$2.07 - $2.22
52 week range
$2.10 - $34
Volume
463,244
Avg. Volume (30 days)
847,885
Market Cap
$125.22M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
57,970,110
Open
$2.13
Previous Close
$2.16
Days Range
$2.07 - $2.22
52 week range
$2.10 - $34
Volume
463,244
Avg. Volume (30 days)
847,885
Market Cap
$125.22M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
57,970,110
Open in:
Open in:
INSIDER TRANSACTIONS FOR GRAPHITE BIO INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Samsara BioCapital, L.P. | 10% Owner | Apr 11, 2022 | Buy | $4.07 | 74,464 | 303,068 | 8,109,314 | Apr 13, 2022, 07:40 PM |
| Samsara BioCapital, L.P. | 10% Owner | Apr 12, 2022 | Buy | $4.08 | 350,000 | 1,428,000 | 8,459,314 | Apr 13, 2022, 07:40 PM |
| Gutry Phil | CHIEF BUSINESS OFFICER | Apr 11, 2022 | Buy | $4.01 | 5,000 | 20,050 | 299,941 | Apr 13, 2022, 07:35 PM |
| Samsara BioCapital, L.P. | 10% Owner | Jan 24, 2022 | Buy | $8.70 | 23,000 | 200,100 | 8,034,850 | Jan 25, 2022, 02:30 PM |
| Samsara BioCapital, L.P. | 10% Owner | Jan 21, 2022 | Buy | $8.99 | 100,000 | 899,000 | 8,011,850 | Jan 25, 2022, 02:30 PM |
| Samsara BioCapital, L.P. | 10% Owner | Jan 19, 2022 | Buy | $9.24 | 54,565 | 504,181 | 7,868,745 | Jan 21, 2022, 01:48 PM |
| Samsara BioCapital, L.P. | 10% Owner | Jan 20, 2022 | Buy | $8.92 | 43,105 | 384,497 | 7,911,850 | Jan 21, 2022, 01:48 PM |
| Samsara BioCapital, L.P. | 10% Owner | Dec 15, 2021 | Buy | $10.19 | 22,329 | 227,533 | 7,814,180 | Dec 20, 2021, 01:46 PM |
| Samsara BioCapital, L.P. | 10% Owner | Nov 22, 2021 | Buy | $10.15 | 201,685 | 2,047,103 | 7,791,851 | Nov 24, 2021, 01:31 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 15, 2021 | Buy | $12.49 | 2,300 | 28,727 | 7,590,166 | Oct 15, 2021, 06:06 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 14, 2021 | Buy | $12.50 | 3,100 | 38,750 | 7,587,866 | Oct 15, 2021, 06:06 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 13, 2021 | Buy | $13.22 | 45,400 | 600,188 | 7,584,766 | Oct 15, 2021, 06:06 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 08, 2021 | Buy | $13.12 | 75,000 | 984,000 | 7,539,366 | Oct 08, 2021, 05:09 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 07, 2021 | Buy | $14.94 | 9,021 | 134,774 | 7,464,366 | Oct 08, 2021, 05:09 PM |
| Samsara BioCapital, L.P. | 10% Owner | Oct 06, 2021 | Buy | $13.83 | 61,475 | 850,199 | 7,455,345 | Oct 08, 2021, 05:09 PM |
| Versant Venture Capital VI, L.P. | 10% Owner | Jun 29, 2021 | Buy | $17.00 | 180,000 | 3,060,000 | 1,707,719 | Jul 01, 2021, 07:01 PM |
| Jerel Davis | Director | Jun 29, 2021 | Buy | $17.00 | 180,000 | 3,060,000 | 1,707,719 | Jul 01, 2021, 07:01 PM |
| Shah Smital | Director | Jun 29, 2021 | Buy | $17.00 | 5,882 | 99,994 | 5,882 | Jul 01, 2021, 07:00 PM |
| Gutry Phil | CHIEF BUSINESS OFFICER | Apr 18, 2021 | Option Exercise | $6.11 | 3,383 | 20,670 | 285,345 | Jul 01, 2021, 07:00 PM |
| Gutry Phil | CHIEF BUSINESS OFFICER | Jan 15, 2021 | Option Exercise | $0.30 | 91,406 | 27,422 | 281,962 | Jul 01, 2021, 07:00 PM |
| JIMENEZ JOSEPH | Director | Jan 14, 2021 | Option Exercise | $0.30 | 49,876 | 14,963 | 153,815 | Jul 01, 2021, 07:00 PM |
| Lehrer-Graiwer Joshua | PRESIDENT AND CEO | Jan 16, 2021 | Option Exercise | $0.30 | 374,013 | 112,204 | 1,153,544 | Jul 01, 2021, 07:00 PM |
| Samsara BioCapital, L.P. | 10% Owner | Jun 29, 2021 | Buy | $17.00 | 500,000 | 8,500,000 | 7,393,870 | Jul 01, 2021, 05:39 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions